JP Morgan Chase
CODX

JP Morgan Chase’s Co-Diagnostics CODX Stock Holding History

JP Morgan Chase’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Sell
3
-47
-94% -$145 ﹤0.01% 7652
2026
Q1 		$85 Buy
50
+28
+127% +$96 ﹤0.01% 7322
2025
Q4 		$112 Sell
22
-10
-31% -$109 ﹤0.01% 7202
2025
Q3 		$332 Sell
32
-443
-93% -$4.12K ﹤0.01% 7079
2025
Q2 		$3.99K Buy
475
+472
+15,733% +$4.42K ﹤0.01% 6443
2025
Q1 		$24 Hold
3
– – ﹤0.01% 7093
2024
Q4 		$57 Hold
3
– – ﹤0.01% 7103
2024
Q3 		$95 Hold
3
– – ﹤0.01% 7009
2024
Q2 		$95 Hold
3
– – ﹤0.01% 6899
2024
Q1 		$85 Hold
3
– – ﹤0.01% 6934
2023
Q4 		$101 Hold
3
– – ﹤0.01% 7123
2023
Q3 		$81 Hold
3
– – ﹤0.01% 6936
2023
Q2 		$84 Hold
3
– – ﹤0.01% 6709
2023
Q1 		$0 Hold
3
– – ﹤0.01% 6756
2022
Q4 		$0 Hold
3
– – ﹤0.01% 6599
2022
Q3 		$0 Hold
3
– – ﹤0.01% 6497
2022
Q2 		$0 Hold
3
– – ﹤0.01% 6513
2022
Q1 		$0 Hold
3
– – ﹤0.01% 6642
2021
Q4 		$1K Hold
3
– – ﹤0.01% 6548
2021
Q3 		$1K Sell
3
-1
-25% -$292 ﹤0.01% 6378
2021
Q2 		$1K Sell
4
-2,498
-100% -$642K ﹤0.01% 6237
2021
Q1 		$715K Buy
2,502
+2,107
+533% +$841K ﹤0.01% 4454
2020
Q4 		$109K Sell
395
-2,448
-86% -$907K ﹤0.01% 4982
2020
Q3 		$1.19M Buy
2,843
+2,122
+294% +$1.09M ﹤0.01% 3554
2020
Q2 		$419K Buy
+721
New +$329K ﹤0.01% 3925

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's CODX Position: Q2 2026 in Review

JP Morgan Chase reduced its Co-Diagnostics (CODX) stake by 94% in Q2 2026, selling an estimated $145 and leaving 3 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #7652.

JP Morgan Chase first reported a position in CODX in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.19M in Q3 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • JP Morgan Chase held 3 shares of Co-Diagnostics worth $9 as of Q2 2026.
  • JP Morgan Chase sold 47 Co-Diagnostics shares in Q2 2026, an estimated $145.
  • Co-Diagnostics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7652 holding.
  • JP Morgan Chase first reported a position in Co-Diagnostics in Q2 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's Co-Diagnostics position peaked at $1.19M in Q3 2020.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.